title: Regulation of kappa opioid receptor mRNA in the rat brain by "binge' pattern cocaine administration and correlation with preprodynorphin mRNA.
abstract: We previously reported that 'binge' pattern administration of cocaine elevates preprodynorphin (ppDyn) mRNA in the caudate-putamen of rats. The present study confirms this finding. In addition, we report here that "binge' pattern administration of cocaine leads to a significant decrease in the mean level of kappa opioid receptor (KOR) mRNA in the substantia nigra, with no significant change in the mean level of KOR mRNA in the caudate-putamen. The decrease in KOR mRNA in the substantia nigra after 3 day or 14 day 'binge' administration of cocaine was comparable to the increase in ppDyn mRNA in the caudate-putamen. While there was no significant change in the mean levels of KOR mRNA in the caudate-putamen following cocaine administration, there was a positive within animal correlation between the levels of ppDyn mRNA and KOR mRNA in the caudate-putamen, both in animals administered saline and in animals receiving 'binge' cocaine for 14 days. Finally, mean levels of ppDyn or KOR mRNA in cocaine treated rats were not different from saline treated controls following a 10 day withdrawal from 14 days of 'binge' cocaine administration. The results provide evidence of regulation of KOR mRNA by cocaine in the substantia nigra.
authors: Rockefeller University, Laboratory of the Biology of Addictive Diseases, New York, NY 10021, USA.
authors: R
authors: R
authors: Spangler
authors: A
authors: A
authors: Ho
authors: Y
authors: Y
authors: Zhou
authors: C E
authors: CE
authors: Maggos
authors: V
authors: V
authors: Yuferov
authors: M J
authors: MJ
authors: Kreek
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002421:Caudate Nucleus / Q000187:drug effects; D011232:Chemical Precipitation; D003042:Cocaine / Q000494:pharmacology*; D018765:Dopamine Uptake Inhibitors / Q000494:pharmacology*; D004334:Drug Administration Schedule; D004399:Dynorphins / Q000235:genetics*; D005786:Gene Expression Regulation / Q000502:physiology; D008297:Male; D011498:Protein Precursors / Q000235:genetics*; D011699:Putamen / Q000187:drug effects; D012333:RNA, Messenger / Q000378:metabolism*; D051381:Rats; D011916:Rats, Inbred F344; D017473:Receptors, Opioid, kappa / Q000235:genetics*; D013378:Substantia Nigra / Q000187:drug effects; D017557:Ventral Tegmental Area / Q000187:drug effects
chemical_list: D018765:Dopamine Uptake Inhibitors; D011498:Protein Precursors; D012333:RNA, Messenger; D017473:Receptors, Opioid, kappa; C036448:pre-prodynorphin; D004399:Dynorphins; D003042:Cocaine